Previous 10 | Next 10 |
2024-06-11 14:00:18 ET Summary Eli Lilly's stock has seen significant gains due to the success of its GLP-1 franchise and the potential of donanemab for Alzheimer's disease. The FDA's Advisory Committee endorsed donanemab for Alzheimer's treatment, but concerns remain post-approva...
2024-06-11 13:25:29 ET The major market averages have shifted lower for the most part on Tuesday ahead of key inflation data and the Federal Reserve’s latest rate decision, but some stocks are still flashing signs of being overbought according to the relative strength index technical...
2024-06-11 08:45:53 ET Palm Beach, FL – June 11, 2024 – FN Media Group News Commentary – In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it was estimated by the National Multipl...
2024-06-11 05:50:00 ET Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it isn't even close. Lilly continues to widen its...
2024-06-10 20:52:27 ET The biotech sector includes companies that develop drugs and diagnostic technologies based on biology. These firms often focus on developing innovative treatments for various medical conditions. Investments in this sector are driven by the potential for significant br...
2024-06-10 20:20:28 ET Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference June 10, 2024 4:00 PM ET Company Participants Patrik Jonsson - Executive Vice President, President of Lilly Diabetes and Obesity and Lilly USA Conference Call ...
2024-06-10 20:17:47 ET Alzheimer’s could eventually be a “very big category” for Eli Lilly & Co (NYSE: LLY), says Dr Scott Gottlieb. He’s the former commission of the U.S. Food & Drug Administration. FDA advisors vote in favour of Lilly’s d...
A look at the top 10 most actives in the United States KWESST Micro Systems Inc. (KWE) rose 117.2% to $0.8686 on volume of 324,599,275 shares NVIDIA Corporation (NVDA) rose 0.7% to $121.79 on volume of 306,257,100 shares Nauticus Robotics Inc. (KITT) rose 49.0% to $0.2309 on volume of 208...
2024-06-10 15:35:10 ET More on Eli Lilly Lilly's donanemab, remternetug set to dominate Alzheimer's treatment by 2030 Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Eli Lilly's Growth And Challenges: A Cautious Buy Weight loss drugs other ben...
2024-06-10 14:55:09 ET Summary Coya Therapeutics is set to initiate a Phase 2 trial in ALS and release the topline results of a Phase 2 trial in Alzheimer's disease in the summer. The company's anti-inflammatory approach has received strong external validation. Recently, small...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...